- Staat
- MD
- Alter
- 18,0
- Geschlecht
- F
- Eingang
- 07.02.2022
- Impfdatum
- 21.01.2022
- Beginn
- 31.01.2022
- Tage bis Beginn
- 10,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Death
Symptomtext
PATIENT WAS WELL ON 01/30/22, WENT TO BED AND DIED IN HER SLEEP
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- -
- Labordaten
- NONE
- Aktuelle Erkrankungen
- DYSMENORRHEA
- Vorgeschichte
- LONG QT SYNDROMES
- Andere Medikamente
- IBUPROFEN FOR MENSTRUAL PAIN IRON 324 MG (NOT REALLY USING)
- Allergien
- NO KNOWN ALLERGIES
- Vorherige Impfungen
- -
- Staat
- TN
- Alter
- 18,0
- Geschlecht
- F
- Eingang
- 27.07.2022
- Impfdatum
- 27.07.2022
- Beginn
- 27.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Dizziness
Loss of consciousness
Pallor
Symptomtext
after vaccination, patient became pale and also reported feeling light headed, and briefly passed out. She did not loss consciousness
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Loss of consciousness
- Hospital-Tage
- -
- Labordaten
- ambulance was called and emt came into clinic to assess patient. no laboratory test performed.
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- mother reports patient had a hx of vagal response as a toddler.
- Andere Medikamente
- noen
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- AR
- Alter
- 16,0
- Geschlecht
- M
- Eingang
- 14.06.2022
- Impfdatum
- 14.06.2022
- Beginn
- 14.06.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Asthenia
Skin discolouration
Syncope
Symptomtext
Patient had a syncope event after the meningococcal immunization. I had administered the 3rd Covid dose and did the menactra. We put him supine and obtained a set of vitals, mom went to get him a apple and juice. Vital WNL. I put a cold rag on his forehead while mom went to get something for him to eat. I stayed with him during that time. He was alert and oriented x3, his color was much better and we kept him here at the office until he knew he could stand and not feel weak. We did not administer the other two immunizations that he was going to have today.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Syncope
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- none
- Andere Medikamente
- n/a
- Allergien
- n/a
- Vorherige Impfungen
- -
- Staat
- SC
- Alter
- 18,0
- Geschlecht
- F
- Eingang
- 21.04.2022
- Impfdatum
- 13.04.2022
- Beginn
- 16.04.2022
- Tage bis Beginn
- 3,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: ja
Presyncope
Symptomtext
vasovagal episode
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Presyncope
- Hospital-Tage
- 2,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- Red dye
- Vorherige Impfungen
- -
- Staat
- IL
- Alter
- 17,0
- Geschlecht
- M
- Eingang
- 05.04.2022
- Impfdatum
- 05.04.2022
- Beginn
- 05.04.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Loss of consciousness
Symptomtext
PT. RECEIVED THE VACCINE AND AFTER 5-6 MINUTES HE PASSED OUT
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Loss of consciousness
- Hospital-Tage
- -
- Labordaten
- NONE
- Aktuelle Erkrankungen
- HISTORY OF PASSING OUT AFTER VACCINATION AND OTHER UNKNOWN MEDICAL CONDITIONS
- Vorgeschichte
- NONE THAT I KNOW
- Andere Medikamente
- NONE
- Allergien
- NONE
- Vorherige Impfungen
- -
- Staat
- MD
- Alter
- 12,0
- Geschlecht
- F
- Eingang
- 21.03.2022
- Impfdatum
- 21.03.2022
- Beginn
- 21.03.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Presyncope
Symptomtext
Vasovagal bout 10 seconds and lied on exam bed. No injury and was oriented.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Presyncope
- Hospital-Tage
- -
- Labordaten
- n/a
- Aktuelle Erkrankungen
- no
- Vorgeschichte
- no
- Andere Medikamente
- no
- Allergien
- n
- Vorherige Impfungen
- -
- Staat
- IN
- Alter
- 17,0
- Geschlecht
- M
- Eingang
- 16.03.2022
- Impfdatum
- 16.03.2022
- Beginn
- 16.03.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Hyperhidrosis
Nausea
Pallor
Supine position
Syncope
Symptomtext
Syncopal episode after HPV vaccination today. Patient became Nauseous and fainted while sitting on exam chair. Pt laid down on exam table and cool compresses applied. Pt not shaking or convulsing. No dyspnea or Tachycardia. + diaphoresis. Pt. pale appearing - no cyanosis. BP taken several minutes after episode while pt diaphoretic and supine. Pt's color quickly returned and disposition returned to normal within 10-15 minutes within 10-15 minutes of laying down and drinking water, eating a snack. Pt did not have anything to eat today far ( episode happened about 12:00pm. Pt stating he was fine to ambulate out-parent requesting a wheelchair. Pt smiling ,alert, and conversant.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Syncope
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- ADHD
- Andere Medikamente
- Adderall 20mg 1 tab po BID
- Allergien
- Seasonal Allergies
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 21,0
- Geschlecht
- F
- Eingang
- 12.03.2022
- Impfdatum
- 12.03.2022
- Beginn
- 12.03.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Dizziness
Immediate post-injection reaction
Syncope
Vomiting
Symptomtext
Immediately upon vaccination, patient exhibited signs of lightheadedness/fainting, as she began to rock back in her chair. I called for assistance from technician and we supported patient. I opened smelling salts and patient revived quickly, asking, "what happened?" She then bent over in her chair and placed her head between her knees, asking for a bucket to vomit. I did not see that she actually vomited. We offered the patient water, which she accepted and began to sip. Within 3-5 minutes, patient said that she was feeling much better, and after approximately 5 minutes, patient indicated that she felt comfortable transitioning to a lying down position, where she remained comfortable and engaged with me for 20 additional minutes. After this time, she stood and reported no lingering effects or concerns. I confirmed that patient would remain in-store to have something to eat. I encouraged her to call or return to the pharmacy if she needed additional assistance. patient indicated that she was feeling fine upon departure and that she would stay in store to have breakfast and that she would consult with pharmacy staff if she had any lingering effect or concern
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Syncope
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- unknown
- Vorgeschichte
- unknown
- Andere Medikamente
- unknown
- Allergien
- unknown
- Vorherige Impfungen
- -
- Staat
- VA
- Alter
- 11,0
- Geschlecht
- F
- Eingang
- 27.04.2022
- Impfdatum
- 26.04.2022
- Beginn
- 26.04.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- SYR / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Chills
Dyspnoea
Pallor
Symptomtext
HPV vaccine, Tdap, meningococcal vaccine given in that order Patient abruptly became short of breath with pallor 0.3 mg EpiPen administered Symptoms abruptly improved Posttreatment side effects included shivering otherwise tolerated administration well
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dyspnoea
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- None
- Allergien
- NKDA
- Vorherige Impfungen
- -
- Staat
- MD
- Alter
- 14,0
- Geschlecht
- F
- Eingang
- 14.02.2022
- Impfdatum
- 14.02.2022
- Beginn
- 14.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Aphasia
Dyskinesia
Dyspnoea
Pallor
Tremor
Symptomtext
Signed consent and center enrolment form obtained. VIS provided, student denies any allergies, and No past medical history. At 11:00am IZs IPV, HBV, Tdap, MCV, MMR and Varicella administered, student stated that she is having difficulty of breathing. Assessed student. At 11:10 student c/o difficulty breathing, B/P 85/57, HR 83, RR 26, O2 Sat 96% alert, oriented to time, place, and person. Pupils equal, round, and reactive to light, Lungs clear bilaterally, Student continue complaining of SOB, lower lip pale, fingers bilaterally pale. Mild Diaphysis 11:23am Epinephrine, (Auto-injectors) 0.3 mg administered by NP. Student started shaking, difficulty to verbalize, facial expression were symmetrical, strong grips bilaterally, and strong bilateral extremities movements. 11:30am normal skin color BP 96/65 HR 80 O2 sat 100%, student stated her breathing is improved. Alert and oriented, School administers, student?s guardian notified, EMS call initiated, student?s guardian notified. EMT arrived brief report given, student transferred to Hospital.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dyspnoea
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- none
- Andere Medikamente
- none
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 16,0
- Geschlecht
- F
- Eingang
- 08.02.2022
- Impfdatum
- 07.02.2022
- Beginn
- 07.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: ja
Chills
Dizziness
Dyspnoea
Electrocardiogram normal
Headache
Pain
Pyrexia
Skin warm
Urine analysis normal
Symptomtext
Mother stated that patient on 2/7/2022 at 8pm was experiencing a very bad headache, felt very hot to touch, dizziness, body chills and shortness of breath. Mother gave the patient her inhaler of albuterol and ibuprofen for pain and fever. Mother then took patient to hospital. At the hospital the medical staff checked the patient urine and did an EKG and results were normal for both exams. They administered oral medication to patient of ibuprofen for pain due to the continuous headache she was having. Patient was then discharged from hospital on 2/8/2022 at 5am.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dyspnoea
- Hospital-Tage
- 1,0
- Labordaten
- On 2/07/2022 a urinalysis and EKG was done on patient in the hospital and both exams were normal.
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Asthma
- Andere Medikamente
- Flovent HFA 44mcg Inhaler, ProAir HFA 108mcg Inhaler
- Allergien
- No Known Allergy
- Vorherige Impfungen
- -
- Staat
- TN
- Alter
- -
- Geschlecht
- F
- Eingang
- 30.11.2021
- Impfdatum
- 18.11.2021
- Beginn
- 18.11.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Headache
Hypotension
Nausea
Tachycardia
Tremor
Vomiting
Symptomtext
headache 10/10; Initial information received on 19-Nov-2021 regarding an unsolicited valid non-serious case from a other health professional via the Agency (under the reference 00865885). This case was linked to case 2021SA392402(CLUSTER). This case involves a 16-year-old female patient who experienced headache 10/10 (headache) after receiving MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE [MENACTRA]. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included MENINGOCOCCAL VACCINE B RFHBPA/FHBPB (TRUMENBA) for Immunisation. On 18-Nov-2021, the patient received a 0.5 mL total dose of suspect MENACTRA (0.25 mL to 2 mL for vaccines or 0.1 mL for tuberculin (TB) skin test-0.5 mL, frequency: once, lot U7208AA and expiration date: 10-FEB-2023) via intramuscular route in the left deltoid for prophylactic vaccination. On 18-Nov-2021, the patient developed a non-serious headache 10/10 (headache) same day following the administration of MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE. It was reported "A nurse is calling to report adverse reactions with two patients after they received the MENACTRA vaccine. Caller is wanting to know if the vaccine is safe to continue to use. Both patients were seen in the emergency room. The status of the first patient has only been reported so far from the emergency room. The first patient had a headache 10/10, body shakes, nausea and vomiting and tachycardia as well as hypotension. Patient was given IV fluids and released. The second patient report a headache 10/10 and no other information as been reported other than the patient went to the emergency room." No laboratory data reported. It was not reported if the patient received a corrective treatment for the event. At time of reporting, the outcome was unknown for the event headache.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Hypotension
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- TRUMENBA
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- SC
- Alter
- 11,0
- Geschlecht
- M
- Eingang
- 18.05.2022
- Impfdatum
- 16.05.2022
- Beginn
- 16.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Diarrhoea
Injection site bruising
Injection site reaction
Injection site swelling
Nausea
Urticaria
Vomiting
Symptomtext
Swollen welts at injection sight turned black and blue. Nausea, Vomiting & Diarrhea starting at 3:30 PM.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Diarrhoea
- Hospital-Tage
- -
- Labordaten
- N/A
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- N/A
- Andere Medikamente
- N/A
- Allergien
- NKDA
- Vorherige Impfungen
- -
- Staat
- GA
- Alter
- 18,0
- Geschlecht
- F
- Eingang
- 05.05.2022
- Impfdatum
- 03.05.2022
- Beginn
- 04.05.2022
- Tage bis Beginn
- 1,0
- Dosis
- 2
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Erythema
Lip swelling
Nausea
Pain
Rash
Symptomtext
Swollen lips, Nausea, Vomiting, Rash over arms and neck, Temp: 96.4. Benedryl started at 10:00am on 05/06/2022-25mg Q 6hrs. Still currently taking benedryl. Complaints of aches and a few very small flat red areas still present.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Nausea
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WV
- Alter
- 17,0
- Geschlecht
- M
- Eingang
- 23.02.2022
- Impfdatum
- 14.02.2022
- Beginn
- 14.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Injection site erythema
Musculoskeletal stiffness
Pain
Pyrexia
Symptomtext
Pt had body aches, fever, stiff neck, and redness at injection site.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site erythema
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- aortic valve stenosis asthma bicuspid aortic valve ECG: sinus bradycardia ECG: sinus tachycardia environmental allergy fall in home gynecomastia hamstring injury heart disease hypercholesterolemia hypertriglyceridemia injury of right hand injury of wrist mild intermittent asthma non-alcoholic fatty liver raised thyroid stimulating hormone level reactive airway disease vitamin D deficiency
- Andere Medikamente
- anastrozole fluoxetine meclizine pantoprazole ProAir HFA tamoxifen Tums E-X
- Allergien
- amoxicillin Bromfed DM dexamethasone dextromethorphan egg Motrin phenylephrine promethazine
- Vorherige Impfungen
- -
- Staat
- DE
- Alter
- 12,0
- Geschlecht
- M
- Eingang
- 14.02.2022
- Impfdatum
- 11.02.2022
- Beginn
- 12.02.2022
- Tage bis Beginn
- 1,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: ja
Dizziness
Erythema
Induration
Injection site pruritus
Pain
Symptomtext
Induration, erythema, pain, pruritis at injection site. Lightheadedness. Mild symptoms several hours after vaccination, worsening the following morning. Went to ED, supportive care provided.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dizziness
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- COVID-19 (one month prior)
- Vorgeschichte
- Asthma, eczema, allergic rhinitis, obesity
- Andere Medikamente
- -
- Allergien
- Penicillin
- Vorherige Impfungen
- -
- Staat
- TN
- Alter
- 16,0
- Geschlecht
- F
- Eingang
- 04.12.2021
- Impfdatum
- 18.11.2021
- Beginn
- 18.11.2021
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: ja
Abdominal pain
Chills
Headache
Nausea
Vomiting
Symptomtext
This is a spontaneous report received from contactable reporter(s) (nurse) from medical information team via Company Representative. A 16 year-old female patient received Meningococcal group B rlp2086 (TRUMENBA,NDC number of Trumenba: 005-0100-10), intramuscular, administered in deltoid left, administration date 18Nov2021 16:26 (Lot number: ER2622, Expiration Date: Jan2024) at the age of 16 years as dose number unknown, 0.5 ml, single for immunisation; Meningococcal vaccine a/c/y/w conj (dip tox) (MENACTRA,manufacturer: Sanofi,NDC number of Menactra: 49281-589-05), administered in arm left, administration date 18Nov2021 (Lot number: U7208AA, Expiration Date: 10Feb2023) as dose number unknown,0.5 ml, single for immunisation. The patient had no relevant medical history. There were no concomitant medications. The following information was reported: HEADACHE (medically significant) with onset 18Nov2021, outcome "recovered" (Nov2021), described as "10/10 headache"; NAUSEA (non-serious) with onset 18Nov2021, outcome "recovered" (Nov2021), described as "nausea"; VOMITING (non-serious) with onset 18Nov2021, outcome "recovered" (Nov2021), described as "vomiting"; CHILLS (non-serious) with onset 18Nov2021, outcome "recovered" (Nov2021), described as "shivering". The events "10/10 headache", "nausea", "vomiting" and "shivering" were evaluated at the emergency room visit. Therapeutic measures were taken as a result of headache, nausea, vomiting, chills.Administered Zofran and Ibuprofen.Vaccination Facility Type was Physician Office. Relevant Tests: None. Event was occurred in 1 hour. Sender's Comments: Based on a drug event temporal association and on the compatibility with the known adverse event profile of the suspect product, the company cannot completely exclude a reasonable possibility that the suspect vaccine Meningococcal group B rlp2086 may have contributed to the onset of reported serious event headache. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Abdominal pain
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Comments: List of non-encoded Patient Relevant History: Patient Other Relevant History 1: None
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TN
- Alter
- 16,0
- Geschlecht
- F
- Eingang
- 04.12.2021
- Impfdatum
- 18.11.2021
- Beginn
- 18.11.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: ja
Abdominal pain
Chills
Headache
Nausea
Vomiting
Symptomtext
This is a spontaneous report received from contactable reporter(s) (nurse) from medical information team via Company Representative. A 16 year-old female patient received Meningococcal group B rlp2086 (TRUMENBA,NDC number of Trumenba: 005-0100-10), intramuscular, administered in deltoid left, administration date 18Nov2021 16:26 (Lot number: ER2622, Expiration Date: Jan2024) at the age of 16 years as dose number unknown, 0.5 ml, single for immunisation; Meningococcal vaccine a/c/y/w conj (dip tox) (MENACTRA,manufacturer: Sanofi,NDC number of Menactra: 49281-589-05), administered in arm left, administration date 18Nov2021 (Lot number: U7208AA, Expiration Date: 10Feb2023) as dose number unknown,0.5 ml, single for immunisation. The patient had no relevant medical history. There were no concomitant medications. The following information was reported: HEADACHE (medically significant) with onset 18Nov2021, outcome "recovered" (Nov2021), described as "10/10 headache"; NAUSEA (non-serious) with onset 18Nov2021, outcome "recovered" (Nov2021), described as "nausea"; VOMITING (non-serious) with onset 18Nov2021, outcome "recovered" (Nov2021), described as "vomiting"; CHILLS (non-serious) with onset 18Nov2021, outcome "recovered" (Nov2021), described as "shivering". The events "10/10 headache", "nausea", "vomiting" and "shivering" were evaluated at the emergency room visit. Therapeutic measures were taken as a result of headache, nausea, vomiting, chills.Administered Zofran and Ibuprofen.Vaccination Facility Type was Physician Office. Relevant Tests: None. Event was occurred in 1 hour. Sender's Comments: Based on a drug event temporal association and on the compatibility with the known adverse event profile of the suspect product, the company cannot completely exclude a reasonable possibility that the suspect vaccine Meningococcal group B rlp2086 may have contributed to the onset of reported serious event headache. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Abdominal pain
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Comments: List of non-encoded Patient Relevant History: Patient Other Relevant History 1: None
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 13,0
- Geschlecht
- F
- Eingang
- 22.09.2021
- Impfdatum
- 20.09.2021
- Beginn
- 20.09.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Dizziness
Headache
Musculoskeletal disorder
Pain in extremity
Symptomtext
Client received vaccinations at 2:00PM she started feeling dizzy and lightheaded around 2:10PM. Client was placed on her back on exam table and mom elevated her legs, applied cold wash cloth and provided orange juice. At 2:20 Mom and I attempted too sit her up but she was still feeling dizzy and lightheaded and was complaining her legs were hurting. At 2:30PM mom and tried to sit her up, which she was able to do. Her back was against the wall and her legs stretched out in front of her. She no longer felt dizzy or lightheaded but was complaining her legs were sore. Waited 5 minutes or so and her legs were still sore, mom and I attempted to get her up and walk. She was able to stand but unable to move her legs. Mom lifted her up and sat her on the exam table. I lifted her right leg and let go ti see if she could hold it up. She was able to briefly. I tried the same thing with the left but she was unable to hold it up. Mom gave her Tylenol 500mg at 3:00PM because she stated she had a headache. 3:10PM we attempted to get her up again and she still was not able to move her legs. I spoke with my Nursing Director. We went in and spoke to mom and encouraged her to take pt. to her PCP or Urgent care. Mom wanted to take her to Urgent care. Placed pt. in wheelchair and mom lifted her into the car. I spoke with mom on 9/21/21 at 9:00AM and she stated that they went to Urgent Care and they sent her to the hospital to be evaluated. Mom stated took her up and did not get home until 1:00AM she said that she was able to walk when she left the hospital but wasn't sure what caused it. Mom stated she would have dad call to giive me additional information but I have yet to hear from him
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dizziness
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 34,0
- Geschlecht
- M
- Eingang
- 20.05.2023
- Impfdatum
- 16.05.2023
- Beginn
- 16.05.2023
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Medication error
No adverse event
Symptomtext
nurse administered an expired Menactra vaccine to a patient with no reported adverse event; Initial information received on 16-May-2023 regarding an unsolicited valid non-serious case received from a other health professional. This case involves a 34 years old male patient who was administered an expired meningococcal A-C-Y-W135 (D CONJ) vaccine [Menactra] vaccine to a patient with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included pneumococcal vaccine CONJ 13V (CRM197) (Prevenar 13) and HIB vaccine (Haemophilus Influenza Type B Vaccine) both for prophylactic vaccination (Immunisation). On 16-May-2023, the patient received a dose of 0.5 ml (frequency: once every 4 years) of suspect meningococcal A-C-Y-W135 (D CONJ) vaccine (Solution for injection) (lot: U7208AA; expiry date: 10-Feb-2023; strength: normal) via intramuscular route in unknown administration site for prophylactic vaccination (Immunisation). On 16-May-2023 the patient was administered an expired meningococcal A-C-Y-W135 (D CONJ) vaccine to a patient with no reported adverse event (expired product administered) (latency: same day). It was reported, " Nurse wants to know what can be done and when to administer the next dose." Action taken was not applicable. At time of reporting, the outcome was Unknown for the event. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- PREVENAR 13; HAEMOPHILUS INFLUENZA TYPE B VACCINE
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 12,0
- Geschlecht
- M
- Eingang
- 16.02.2023
- Impfdatum
- 13.02.2023
- Beginn
- 13.02.2023
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Medication error
No adverse event
Symptomtext
patient was given expired menactra this morning with no reported adverse event; Initial information received on 13-Feb-2023 regarding an unsolicited valid non-serious case received from a other health professional. This case involves a 12 years old male patient who was given expired meningococcal A-C-Y-W135 (D CONJ) vaccine [Menactra] this morning with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included HPV vaccine, influenza vaccine (flu [influenza vaccine]) and diphtheria vaccine toxoid, pertussis vaccine acellular, tetanus vaccine toxoid (TDAP) all for Prophylactic vaccination. On 13-Feb-2023 at around 10.30, the patient received expired dose of 0.5 ml suspect meningococcal A-C-Y-W135 (D CONJ) vaccine solution for injection (lot: U7208AA, expiry date: 10-Feb-2023) via unknown route in unknown administration site for immunization with no reported adverse event (expired product administered). Action taken: not applicable. At time of reporting, the outcome was Unknown. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- HPV VACCINE; FLU [INFLUENZA VACCINE]; TDAP
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 12,0
- Geschlecht
- F
- Eingang
- 06.09.2022
- Impfdatum
- 18.08.2022
- Beginn
- 06.09.2022
- Tage bis Beginn
- 19,0
- Dosis
- 4
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Extra dose administered
Product administered to patient of inappropriate age
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Extra dose administered
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- noe
- Andere Medikamente
- none
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- NH
- Alter
- 11,0
- Geschlecht
- F
- Eingang
- 24.08.2022
- Impfdatum
- 24.08.2022
- Beginn
- 24.08.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product preparation issue
Symptomtext
Patient given 0.2mL of undiluted Pfizer pediatric 5-11.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product preparation issue
- Hospital-Tage
- -
- Labordaten
- None at this time.
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Insomnia, GERD, GAD, depression, nocturnal headaches
- Andere Medikamente
- None
- Allergien
- NKA
- Vorherige Impfungen
- -
- Staat
- NC
- Alter
- 12,0
- Geschlecht
- F
- Eingang
- 24.08.2022
- Impfdatum
- 23.08.2022
- Beginn
- 24.08.2022
- Tage bis Beginn
- 1,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Peripheral swelling
Symptomtext
Approximately two hours after patient was seen, patient's mother called stating that patient was seen today for "tetanus shot and now her hand is swollen". A nurse attempted to call patient's mother back to discuss this, but was unable to make contact so left a message advising patient to go to local urgent care for evaluation. I have tried calling patient's mother today to check on patient, but have been unable to reach her at this time.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Peripheral swelling
- Hospital-Tage
- -
- Labordaten
- unknown
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- None that I'm aware of
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- OK
- Alter
- 15,0
- Geschlecht
- M
- Eingang
- 01.08.2022
- Impfdatum
- 01.07.2019
- Beginn
- 21.07.2022
- Tage bis Beginn
- 1.116,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Inappropriate schedule of product administration
Symptomtext
A fifteen year old was administered a Menactra booster a year too soon. His last injection was 3 years ago with no adverse event; Initial information received on 25-Jul-2022 and live follow-up received on same day (processed together) regarding an unsolicited valid non-serious case received from a other health professional. This case involves a 15 years old male patient who was administered a menactra booster a year too soon. his last injection was 3 years ago with no adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On an unknown date in Jul-2019, the patient received a 0.5ml 1 X(once) dose of suspect MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE (strength, formulation was unknown, lot U7208AA and expiry date: 20-Feb-2023) via unknown route in unknown administration site for Immunization. On 21-Jul-2022 the patient developed a non-serious event of a fifteen year old was administered a menactra booster a year too soon. his last injection was 3 years ago with no adverse event (inappropriate schedule of product administration) (Latency: 3 years) following the administration of MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE. Action taken : not applicable. Outcome: Unknown This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Inappropriate schedule of product administration
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 16,0
- Geschlecht
- F
- Eingang
- 21.07.2022
- Impfdatum
- 12.07.2022
- Beginn
- 12.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Product administration error
Symptomtext
Vaccine Admin error non-viable vaccine
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product administration error
- Hospital-Tage
- -
- Labordaten
- N/A
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- N/A
- Andere Medikamente
- N/A
- Allergien
- N/A
- Vorherige Impfungen
- -
- Staat
- KS
- Alter
- 56,0
- Geschlecht
- M
- Eingang
- 11.07.2022
- Impfdatum
- 22.06.2022
- Beginn
- 22.06.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Expired product administered
Symptomtext
Varicella diluted w/expired Diluent.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- Unknown
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- NY
- Alter
- 12,0
- Geschlecht
- F
- Eingang
- 17.06.2022
- Impfdatum
- 09.06.2022
- Beginn
- 09.06.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Medication error
No adverse event
Product use issue
Symptomtext
a nurse inadvertently administered MENACTRA to a patient who was supposed to receive Gardasil with no reported adverse event; had just received a dose of MENACTRA on 10Aug202, she received another dose of MENACTRA too early with no reported adverse event; Initial information received on 10-Jun-2022 regarding an unsolicited valid non-serious case received from a other health professional via call center. This case involves a 12 years old female patient who was inadvertently administered menactra by nurse who was supposed to receive gardasil with no reported adverse event and had just received a dose of menactra on 10aug2021, she received another dose of menactra too early with no reported adverse event while receiving vaccine Meningococcal A-C-Y-W135 (D Conj) Vaccine [Menactra]. The patient's past vaccination(s) included Menactra on 10-AUG-2021. The patient's past medical history, medical treatment(s) and family history were not provided. Concomitant medications included Hpv Vaccine Vlp Rl1 4v (Yeast) (Gardasil) for Prophylactic vaccination. On 09-Jun-2022, the patient received a 0.5 ml dose of suspect meningococcal A-C-Y-W135 (D CONJ) vaccine lot U7208AA, expiry date: 10-Feb-2023, frequency: once unknown strength and formulation via intramuscular route in the right deltoid as immunization. On 09-JUN-2022 the patient developed non-serious events a nurse inadvertently administered menactra to a patient who was supposed to receive gardasil with no reported adverse event (wrong product administered) and had just received a dose of menactra on 10aug2021, she received another dose of menactra too early with no reported adverse event (product use issue) latency: same day following the administration of meningococcal a-c-y-w135 (d conj) vaccine. Action taken was not applicable. It was not reported if the patient received a corrective treatment for both the events. At time of reporting, the outcome was Unknown for both the events. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Medication error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NM
- Alter
- 16,0
- Geschlecht
- M
- Eingang
- 17.05.2022
- Impfdatum
- 04.03.2022
- Beginn
- 04.03.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Extra dose administered
Symptomtext
Patient's mother stated to physician that patient needed their first dose Covid vaccine, so Covid Vaccine First Dose appointment created per protocol. Patient mother signed all required paperwork. Prior to vaccine administration, RN gave the opportunity for questions or concerns. After vaccine was administered to the patient, patient's mother asked if they could receive a new card with all administrations present. At this time RN pulled up the Immunization registry and discovered that patient had already received 3 doses of Pfizer vaccine with the most recent being on 2/4/22. Patient held for observation with no adverse reactions or physiological distress observed prior to patient leaving clinic. Parent was counseled on signs and symptoms of myocarditis.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Extra dose administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- IN
- Alter
- 11,0
- Geschlecht
- M
- Eingang
- 14.05.2022
- Impfdatum
- 02.05.2022
- Beginn
- 02.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Medication error
No adverse event
Product storage error
Symptomtext
vaccines given post excursion (with no reported adverse event); vaccines being given post temperature excursion (with no reported adverse event); Initial information received on 06-May-2022 regarding an unsolicited valid non-serious case received from other health professional. This case involves a 11 years old male patient who experienced vaccines given post excursion (with no reported adverse event) while receiving meningococcal A-C-Y-W135 (D conj) vaccine [Menactra]. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included diphtheria vaccine toxoid, pertussis vaccine acellular 5-component, tetanus vaccine toxoid (Adacel) for Prophylactic vaccination; and hpv vaccine (HPV vaccine) for prophylactic vaccination. On 02-May-2022, the patient received a dose of 0.5 ml 1 day total Strength: standard suspect meningococcal a-c-y-w135 (d conj) vaccine lot U7208AA, expiry date:10-Feb-2023 via intramuscular route in the left deltoid for prophylactic vaccination. On 02-May-2022 (Latency: same day) vaccines given post excursion (with no reported adverse event) (poor quality product administered) and (product temperature excursion issue). This situation was reported as a medication error due to vaccines being given post temperature excursion. Action taken was not applicable. At time of reporting, the outcome was Unknown for all the events. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.; Sender's Comments: PENTACEL case 01092869: PENTACEL case 01092879: QUADRACEL case 01092814: QUADRACEL case 01092832: QUADRACEL case 01092891: ADACEL case: 01092687: DAPTACEL case: 01092746: FLUZONE QIV case 01092709: FLUZONE QIV case 01092741: FLUZONE QIV case 01092787: FLUZONE QIV case 01092803: FLUZONE QIV case 01092850:
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Medication error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- ADACEL; HPV VACCINE
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 12,0
- Geschlecht
- M
- Eingang
- 26.04.2022
- Impfdatum
- 19.04.2022
- Beginn
- 19.04.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / RL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Extra dose administered
No adverse event
Symptomtext
Patient received MMRV and Varicella. No adverse outcome. No treatment needed.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Extra dose administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- N/A
- Andere Medikamente
- N/A
- Allergien
- N/A
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 17,0
- Geschlecht
- F
- Eingang
- 15.04.2022
- Impfdatum
- 08.03.2022
- Beginn
- 08.03.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Extra dose administered
Symptomtext
DTAP was given when DTAP-HEPB-IPV was given. No adverse symptoms in the clinic. Tried to call pt to see how she was doing, no response. Left voicemail.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Extra dose administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- N/A
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 13,0
- Geschlecht
- F
- Eingang
- 18.02.2022
- Impfdatum
- 18.02.2022
- Beginn
- 18.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Inappropriate schedule of product administration
Symptomtext
Nurse gave MMR vaccine 8 days early in error. No side effects occurred. Nurse noticed error right after vaccinating the patient.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Inappropriate schedule of product administration
- Hospital-Tage
- -
- Labordaten
- n/a
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- none
- Andere Medikamente
- none
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- SC
- Alter
- -
- Geschlecht
- U
- Eingang
- 12.02.2022
- Impfdatum
- -
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product storage error
Symptomtext
had a power outages and they packed the vaccines up to be moved to another refrigerator with a generator but no one put a data logger in the cooler.; Initial information received on 27-Jan-2022 regarding an unsolicited valid non-serious case received from a other health professional. This case involves a patient with unknown demographics who had a power outages and they packed the vaccines up to be moved to another refrigerator with a generator but no one put a data logger in the cooler while having [DAPTACEL], [IPOL],[PENTACEL], [ADACEL], (D CONJ) [MENACTRA] and [FLUZONE QUADRIVALENT]. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On an unknown date, the patient received a dose of suspect INFLUENZA QUADRIVAL A-B VACCINE, with an unknown dose ,frequency, route (lot UT7356LA). On an unknown date, the patient received a dose of suspect MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE with an unknown dose ,frequency, route (lot U7208AA). On an unknown date, the patient received a dose of suspect DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE with an unknown dose ,frequency, route (lot C5854AA). On an unknown date, the patient received a dose of suspect DIPHTHERIA/TETANUS/5 HYBRID AC PERTUSSIS/IPV(MRC5)/HIB(PRP/T) VACCINE with an unknown dose ,frequency, route (lot UJ580AAA). On an unknown date, the patient received a dose of suspect IPV (VERO) lot U1C571M via unknown route in unknown administration site. On an unknown date, the patient received a dose of suspect DIPHTHERIA-15/TETANUS/5 AC PERTUSSIS VACCINE with an unknown dose ,frequency, route (lot C5774BA). On an unknown date the patient had a power outages and they packed the vaccines up to be moved to another refrigerator with a generator but no one put a data logger in the cooler. (product temperature excursion issue) (unknown latency) following the administration of INFLUENZA QUADRIVAL A-B VACCINE. Action taken was not applicable. It was not reported if the patient received a corrective treatment for the event (had a power outages and they packed the vaccines up to be moved to another refrigerator with a generator but no one put a data logger in the cooler.). At time of reporting, the outcome was Unknown for the event had a power outages and they packed the vaccines up to be moved to another refrigerator with a generator but no one put a data logger in the cooler.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -